Three-week radiation course a safe option for breast cancer patients undergoing reconstruction, trial shows
Results of a national clinical trial led by the Alliance for Clinical Trials in Oncology in conjunction with NRG Oncology and the Canadian Cancer Trials Group show that a shorter, three-week radiation schedule following a mastectomy is as safe and effective as the standard five-week treatment for women undergoing breast reconstruction. The results of the RT CHARM trial (Alliance A221505) are…
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Clinical support tool helps primary care health professionals detect and treat chronic kidney disease
United Kingdom
-
Potassium binder may ease the burden of dietary potassium restriction in people on dialysis
United Kingdom
-
Fruits and vegetables outperform medication for treating metabolic acidosis in chronic kidney disease
United Kingdom
-
Social determinants linked with kidney failure risk among survivors of critical illness and acute kidney injury
United Kingdom
-
Standardized kidney biopsy protocol is safe in high-risk patients
United Kingdom
-
US cannabis legalization linked to rise in cardiovascular hospital admissions
United Kingdom
-
Early uptake for oral semaglutide proves rapid relative to injectables
United Kingdom
-
Beyond the ACE score: A single number may miss the complexity of childhood trauma, study suggests
United Kingdom